Table 2. 30-day mortality according to predefined ProADM categories.

	ProADM categories						P value
Adverse event (95% CI)	n	ProADM ≤0.75nmol/L	n	ProADM >0.75–1.5nmol/L	n	ProADM >1.5nmol/L
Primary endpoint
30-day mortality	2972	0.6 (0.4–0.9)	2382	4.5 (3.6–5.3)	1232	15.4 (13.4–17.4)	<0.0001

ProADM, pro-adrenomedullin; CI, confidence interval.